NVO

NVO

USD

Novo Nordisk A/S Common Stock

$45.700-0.520 (-1.125%)

Echtzeitkurs

Healthcare
Drug Manufacturers - General
Dänemark

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$46.220

Hoch

$46.360

Tief

$45.570

Volumen

37.86M

Unternehmensfundamentaldaten

Marktkapitalisierung

210.1B

Branche

Drug Manufacturers - General

Land

Denmark

Handelsstatistiken

Durchschnittliches Volumen

15.16M

Börse

NYQ

Währung

USD

52-Wochen-Spanne

Tief $45.05Aktuell $45.700Hoch $112.52

Ähnliche Nachrichten

CNBC

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

Mehr anzeigen
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
CNBC

Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech

The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.

Mehr anzeigen
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
CNBC

November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk

Here are five key things investors need to know to start the trading day.

Mehr anzeigen
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
CNBC

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.

Mehr anzeigen
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound